SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-041104
Filing Date
2009-07-01
Accepted
2009-06-30 18:30:41
Documents
7
Period of Report
2009-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-16940_18k.htm 8-K 35575
2 EX-10.1 a09-16940_1ex10d1.htm EX-10.1 445684
3 EX-10.2 a09-16940_1ex10d2.htm EX-10.2 454081
4 EX-99.1 a09-16940_1ex99d1.htm EX-99.1 20819
5 GRAPHIC g169401mmi001.jpg GRAPHIC 3090
6 GRAPHIC g169401kl07i001.jpg GRAPHIC 2096
7 GRAPHIC g169401kl07i002.jpg GRAPHIC 3189
  Complete submission text file 0001104659-09-041104.txt   969729
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14732 | Film No.: 09920274
SIC: 2835 In Vitro & In Vivo Diagnostic Substances